PubRank

Jörg D Hoheisel

Author PubWeight™ 95.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods 2007 2.04
2 Genome-wide analysis of the response to cell wall mutations in the yeast Saccharomyces cerevisiae. J Biol Chem 2003 1.99
3 Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010 1.82
4 Transcriptome analysis of differentiating trypanosomes reveals the existence of multiple post-transcriptional regulons. BMC Genomics 2009 1.68
5 Targeted next-generation sequencing by specific capture of multiple genomic loci using low-volume microfluidic DNA arrays. Anal Bioanal Chem 2008 1.68
6 Heat shock causes a decrease in polysomes and the appearance of stress granules in trypanosomes independently of eIF2(alpha) phosphorylation at Thr169. J Cell Sci 2008 1.64
7 Microarray data warehouse allowing for inclusion of experiment annotations in statistical analysis. Bioinformatics 2002 1.37
8 Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 2012 1.36
9 Solid supports for microarray immunoassays. J Mol Recognit 2003 1.33
10 Generation of high density protein microarrays by cell-free in situ expression of unpurified PCR products. Mol Cell Proteomics 2006 1.28
11 Antibody microarrays: an evaluation of production parameters. Proteomics 2003 1.28
12 Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med 2013 1.23
13 Glucose triggers different global responses in yeast, depending on the strength of the signal, and transiently stabilizes ribosomal protein mRNAs. Mol Microbiol 2003 1.22
14 Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics 2010 1.21
15 Optimal design of microarray immunoassays to compensate for kinetic limitations: theory and experiment. Mol Cell Proteomics 2006 1.18
16 Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 2002 1.17
17 Kinetics of antigen binding to antibody microspots: strong limitation by mass transport to the surface. Proteomics 2006 1.13
18 The genome structure of Pseudomonas putida: high-resolution mapping and microarray analysis. Environ Microbiol 2002 1.13
19 A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics 2009 1.11
20 Functional genomics of stress response in Pseudomonas putida KT2440. J Bacteriol 2006 1.09
21 Analysis of stage-specific gene expression in the bloodstream and the procyclic form of Trypanosoma brucei using a genomic DNA-microarray. Mol Biochem Parasitol 2002 1.09
22 Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression. Nucleic Acids Res 2011 1.08
23 The RNA helicase DHH1 is central to the correct expression of many developmentally regulated mRNAs in trypanosomes. J Cell Sci 2010 1.06
24 Functional analysis of Trypanosoma brucei PUF1. Mol Biochem Parasitol 2006 1.05
25 What's in the genome of a filamentous fungus? Analysis of the Neurospora genome sequence. Nucleic Acids Res 2003 1.05
26 DNA microarray analysis of pancreatic malignancies. Pancreatology 2004 1.05
27 The yeast transcriptome in aerobic and hypoxic conditions: effects of hap1, rox1, rox3 and srb10 deletions. Mol Microbiol 2002 1.02
28 Expression profiling of glial genes during Drosophila embryogenesis. Dev Biol 2006 1.01
29 Therapeutic and diagnostic applications of nanoparticles. Curr Drug Targets 2011 1.00
30 Antibody microarrays: promises and problems. Biotechniques 2002 1.00
31 Integration of GO annotations in Correspondence Analysis: facilitating the interpretation of microarray data. Bioinformatics 2005 1.00
32 Pancreatic cancer susceptibility loci and their role in survival. PLoS One 2011 0.98
33 Multiplex approaches in protein microarray technology. Expert Rev Proteomics 2005 0.97
34 Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies. Proteomics 2007 0.97
35 Sed1p and Srl1p are required to compensate for cell wall instability in Saccharomyces cerevisiae mutants defective in multiple GPI-anchored mannoproteins. Mol Microbiol 2004 0.97
36 Peptide nucleic acids on microarrays and other biosensors. Trends Biotechnol 2004 0.96
37 Decoding pooled RNAi screens by means of barcode tiling arrays. BMC Genomics 2010 0.95
38 Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines. Nucleic Acids Res 2005 0.95
39 Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen. J Proteome Res 2011 0.94
40 Specialized DNA arrays for the differentiation of pancreatic tumors. Clin Cancer Res 2005 0.94
41 Antibody microarrays: the crucial impact of mass transport on assay kinetics and sensitivity. Expert Rev Mol Diagn 2006 0.93
42 Creation of a minimal tiling path of genomic clones for Drosophila: provision of a common resource. Biotechniques 2004 0.93
43 PNA microarrays for hybridisation of unlabelled DNA samples. Nucleic Acids Res 2003 0.93
44 Oncoproteomic profiling with antibody microarrays. Genome Med 2009 0.92
45 A transcriptome analysis of isoamyl alcohol-induced filamentation in yeast reveals a novel role for Gre2p as isovaleraldehyde reductase. FEMS Yeast Res 2006 0.92
46 Diagnostic values of GHSR DNA methylation pattern in breast cancer. Breast Cancer Res Treat 2012 0.92
47 Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells. Biochem Pharmacol 2009 0.92
48 Manufacturing DNA microarrays from unpurified PCR products. Nucleic Acids Res 2002 0.91
49 Do we use the appropriate controls for the identification of informative methylation markers for early cancer detection? Genome Biol 2008 0.91
50 A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype. Breast Cancer Res 2013 0.89
51 Methods for analyzing and quantifying protein-protein interaction. Expert Rev Proteomics 2014 0.89
52 Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system. PLoS One 2012 0.89
53 Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer 2012 0.89
54 Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. Curr Drug Discov Technol 2010 0.88
55 Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta Med 2010 0.87
56 Utilising the left-helical conformation of L-DNA for analysing different marker types on a single universal microarray platform. Nucleic Acids Res 2006 0.87
57 Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br J Pharmacol 2011 0.87
58 ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 2013 0.86
59 Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity? Virchows Arch 2004 0.86
60 Identification of malignancy factors by analyzing cystic tumors of the pancreas. Pancreatology 2008 0.85
61 Single-step procedure for the isolation of proteins at near-native conditions from mammalian tissue for proteomic analysis on antibody microarrays. J Proteome Res 2010 0.84
62 Another side of genomics: synthetic biology as a means for the exploitation of whole-genome sequence information. J Biotechnol 2006 0.83
63 Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine. J Cell Sci 2013 0.83
64 Systematic interpretation of microarray data using experiment annotations. BMC Genomics 2006 0.83
65 Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines. J Proteomics 2012 0.82
66 Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays. Proteomics 2010 0.82
67 Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol Biomarkers Prev 2012 0.81
68 Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. Planta Med 2010 0.81
69 Transcript profiling identifies novel key players mediating the growth inhibitory effect of NS-398 on human pancreatic cancer cells. Eur J Pharmacol 2010 0.81
70 The transcriptome of the colonial marine hydroid Hydractinia echinata. FEBS J 2009 0.81
71 Secretome profiling with antibody microarrays. Mol Biosyst 2011 0.81
72 Assessment and optimisation of normalisation methods for dual-colour antibody microarrays. BMC Bioinformatics 2010 0.81
73 Somatic mutations in exocrine pancreatic tumors: association with patient survival. PLoS One 2013 0.81
74 Optimization of candidate-gene SNP-genotyping by flexible oligonucleotide microarrays; analyzing variations in immune regulator genes of hay-fever samples. BMC Genomics 2007 0.81
75 High-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistance. PLoS One 2010 0.80
76 Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells--differences of relevance for adenoviral oncolysis. PLoS One 2011 0.80
77 Monitoring methylation changes in cancer. Adv Biochem Eng Biotechnol 2007 0.80
78 DNA-probes for the highly sensitive identification of single nucleotide polymorphism using single-molecule spectroscopy. FEBS Lett 2007 0.80
79 Analysis of DNA-protein interactions: from nitrocellulose filter binding assays to microarray studies. Anal Bioanal Chem 2010 0.80
80 Late ischemic preconditioning of the myocardium alters the expression of genes involved in inflammatory response. FEBS Lett 2003 0.79
81 Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses. Proteomics 2014 0.79
82 Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays. Proteomics Clin Appl 2013 0.79
83 Analysis of DNA-microarrays produced by inverse in situ oligonucleotide synthesis. J Biotechnol 2002 0.78
84 RNA-directed epigenomic reprogramming: an emerging principle of a more targeted cancer therapy? Genes Chromosomes Cancer 2011 0.78
85 Identification of single-point mutations in mycobacterial 16S rRNA sequences by confocal single-molecule fluorescence spectroscopy. Nucleic Acids Res 2006 0.78
86 DNA microarray preparation by light-controlled in situ synthesis. Curr Protoc Nucleic Acid Chem 2005 0.78
87 Robust protein profiling with complex antibody microarrays in a dual-colour mode. Methods Mol Biol 2011 0.77
88 Clinical proteomics: promises, challenges and limitations of affinity arrays. Proteomics Clin Appl 2015 0.77
89 Proteome variations in pancreatic stellate cells upon stimulation with proinflammatory factors. J Biol Chem 2013 0.77
90 Analysis of nutrient-dependent transcript variations in Neurospora crassa. Fungal Genet Biol 2003 0.77
91 The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense. PLoS One 2013 0.77
92 Arrayed primer extension on in situ synthesized 5'-->3' oligonucleotides in microchannels. N Biotechnol 2008 0.76
93 In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts. PLoS One 2013 0.76
94 Genotypic resistance testing in HIV by arrayed primer extension. Anal Bioanal Chem 2008 0.76
95 High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells. BMC Genomics 2014 0.75
96 Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells. Neoplasia 2007 0.75
97 Use of complex DNA and antibody microarrays as tools in functional analyses. Comp Funct Genomics 2003 0.75
98 GHSR hypermethylation: a promising pan-cancer marker. Cell Cycle 2015 0.75
99 Synthesis of 5'-O-phosphoramidites with a photolabile 3'-O-protecting group. Curr Protoc Nucleic Acid Chem 2004 0.75
100 Derivatization of glass and polypropylene surfaces. Curr Protoc Nucleic Acid Chem 2004 0.75
101 Solid type clear cell carcinoma of the pancreas: differential diagnosis of an unusual case and review of the literature. Virchows Arch 2007 0.75
102 Peptide nucleic acid microarrays. Methods Mol Biol 2004 0.75
103 A universally applicable process for preparing stoichiometrically 1:1 labelled functional proteins. Proteomics 2011 0.75
104 Spectrally resolved fluorescence lifetime imaging microscopy (SFLIM)--an appropriate method for imaging single molecules in living cells. Anal Bioanal Chem 2006 0.75
105 Fluorescent sample labeling for DNA microarray analyses. Methods Mol Biol 2004 0.75